Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 23885930)

1.

Contemporary and optimal medical management of peripheral arterial disease.

Tattersall MC, Johnson HM, Mason PJ.

Surg Clin North Am. 2013 Aug;93(4):761-78, vii. doi: 10.1016/j.suc.2013.04.009. Epub 2013 Jun 18. Review.

PMID:
23885930
2.
3.

Impact of pharmacologic interventions on peripheral artery disease.

Pineda JR, Kim ES, Osinbowale OO.

Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):510-20. doi: 10.1016/j.pcad.2014.12.001. Epub 2014 Dec 2. Review.

PMID:
25475072
4.

Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication.

Agrawal K, Eberhardt RT.

Cardiol Clin. 2015 Feb;33(1):111-37. doi: 10.1016/j.ccl.2014.09.010.

PMID:
25439335
5.

Pharmacology in peripheral arterial disease: what the interventional radiologist needs to know.

Atturu G, Homer-Vanniasinkam S, Russell DA.

Semin Intervent Radiol. 2014 Dec;31(4):330-7. doi: 10.1055/s-0034-1393969. Review.

PMID:
25435658
6.

Conditions presenting with symptoms of peripheral arterial disease.

Sharma AM, Norton PT, Zhu D.

Semin Intervent Radiol. 2014 Dec;31(4):281-91. doi: 10.1055/s-0034-1393963. Review.

PMID:
25435652
7.

[Is there still an actual place for cardiovascular prevention in the elderly? Focus on antiplatelet and lipid lowering agents].

Radermecker RR, Lancellotti P.

Rev Med Liege. 2014 May-Jun;69(5-6):318-22. Review. French.

PMID:
25065239
8.

Healthcare quality indicators of peripheral artery disease based on systematic reviews.

Bellmunt S, Roqué M, Osorio D, Pardo H, Escudero JR, Bonfill X.

Eur J Vasc Endovasc Surg. 2014 Jul;48(1):60-9. doi: 10.1016/j.ejvs.2014.02.001. Epub 2014 Mar 17. Review.

PMID:
24650396
9.

Non-coronary atherosclerosis.

Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, Schouten O, Lekakis J, Amann-Vesti B, Siclari F, Poredos P, Novo S, Brodmann M, Schulte KL, Vlachopoulos C, De Caterina R, Libby P, Baumgartner I; European Society of Cardiology Working Group on Peripheral Circulation.

Eur Heart J. 2014 May;35(17):1112-9. doi: 10.1093/eurheartj/ehu071. Epub 2014 Mar 3. Review.

10.

Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.

J Atheroscler Thromb. 2013;20(12):850-60. Epub 2013 Dec 10. No abstract available.

11.

Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.

J Atheroscler Thromb. 2013;20(12):835-49. Epub 2013 Oct 29. No abstract available.

12.

Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.

Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society (JAS).

J Atheroscler Thromb. 2013;20(7):603-15. Epub 2013 Jul 25. No abstract available.

13.

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.

Beckman JA, Paneni F, Cosentino F, Creager MA.

Eur Heart J. 2013 Aug;34(31):2444-52. doi: 10.1093/eurheartj/eht142. Epub 2013 Apr 26. Review.

14.

Medical management for chronic atherosclerotic peripheral arterial disease.

Ali FN, Carman TL.

Drugs. 2012 Nov 12;72(16):2073-85. doi: 10.2165/11640810-000000000-00000. Review.

PMID:
23046179
15.

Medical therapy for peripheral arterial disease.

Simmons A, Steffen K, Sanders S.

Curr Opin Cardiol. 2012 Nov;27(6):592-7. doi: 10.1097/HCO.0b013e328357428a. Review.

PMID:
23032711
16.
18.

Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care.

Garimella PS, Hart PD, O'Hare A, DeLoach S, Herzog CA, Hirsch AT.

Am J Kidney Dis. 2012 Oct;60(4):641-54. doi: 10.1053/j.ajkd.2012.02.340. Epub 2012 May 5. Review.

PMID:
22560831
19.

Chapter III: Management of cardiovascular risk factors and medical therapy.

Diehm N, Schmidli J, Setacci C, Ricco JB, de Donato G, Becker F, Robert-Ebadi H, Cao P, Eckstein HH, De Rango P, Teraa M, Moll FL, Dick F, Davies AH, Lepäntalo M, Apelqvist J.

Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S33-42. doi: 10.1016/S1078-5884(11)60011-7. Review.

20.

Novel treatments for cardiovascular disease prevention.

Huffman MD, Bhatnagar D.

Cardiovasc Ther. 2012 Oct;30(5):257-63. doi: 10.1111/j.1755-5922.2011.00280.x. Epub 2011 May 31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk